IRVING, Bryan,CHEUNG, Jeanne,CHIU, Henry,LEHAR, Sophie M.,MAECKER, Heather,MARIATHASAN, Sanjeev,WU, Yan
申请号：
AU2018203226
公开号：
AU2018203226A1
申请日:
2018.05.09
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018203226A120180531.pdf#####Abstract of the Disclosure The present application relates to anti-PD-Li antibodies, nucleic acid encoding the same, 5 therapeutic compositions thereof, and their use enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity. 10250257_1 (GHMatters) P86802.AU.2
